2021 Q4 Form 10-Q Financial Statement
#000156459022004413 Filed on February 09, 2022
Income Statement
| Concept | 2021 Q4 | 2020 Q4 |
|---|---|---|
| Revenue | $141.0M | $152.5M |
| YoY Change | -7.58% | 23.24% |
| Cost Of Revenue | $130.9M | $127.9M |
| YoY Change | 2.33% | 55.98% |
| Gross Profit | $10.09M | $24.59M |
| YoY Change | -58.96% | -35.65% |
| Gross Profit Margin | 7.16% | 16.12% |
| Selling, General & Admin | $116.8M | $144.1M |
| YoY Change | -18.91% | -24.65% |
| % of Gross Profit | 1157.93% | 586.04% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $30.02M | $32.40M |
| YoY Change | -7.35% | 6.37% |
| % of Gross Profit | 297.49% | 131.79% |
| Operating Expenses | $116.8M | $144.1M |
| YoY Change | -18.91% | -36.92% |
| Operating Profit | -$150.0M | -$553.6M |
| YoY Change | -72.91% | 191.08% |
| Interest Expense | $26.41M | $1.030M |
| YoY Change | 2463.88% | -54.02% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $34.28M | -$290.6M |
| YoY Change | -111.8% | 3400.81% |
| Pretax Income | -$115.7M | -$844.9M |
| YoY Change | -86.31% | 476.3% |
| Income Tax | -$183.0K | -$15.60M |
| % Of Pretax Income | ||
| Net Earnings | -$108.9M | -$904.4M |
| YoY Change | -87.96% | 889.97% |
| Net Earnings / Revenue | -77.27% | -592.93% |
| Basic Earnings Per Share | -$0.28 | -$2.43 |
| Diluted Earnings Per Share | -$0.28 | -$2.43 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 393.8M | 372.9M |
| Diluted Shares Outstanding | 393.8M | 372.9M |
Balance Sheet
| Concept | 2021 Q4 | 2020 Q4 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.423B | $1.594B |
| YoY Change | -10.7% | -29.73% |
| Cash & Equivalents | $193.5M | $825.0M |
| Short-Term Investments | $807.9M | $768.6M |
| Other Short-Term Assets | $98.48M | $19.01M |
| YoY Change | 417.94% | -83.41% |
| Inventory | $365.8M | $394.0M |
| Prepaid Expenses | $38.42M | |
| Receivables | $82.55M | $74.57M |
| Other Receivables | $18.35M | $6.338M |
| Total Short-Term Assets | $1.988B | $2.172B |
| YoY Change | -8.45% | 5150.36% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.080B | $1.148B |
| YoY Change | -5.94% | -33.44% |
| Goodwill | $1.988B | $1.918B |
| YoY Change | 3.67% | |
| Intangibles | $338.8M | |
| YoY Change | ||
| Long-Term Investments | $898.5M | $16.99M |
| YoY Change | 5187.76% | -96.42% |
| Other Assets | $15.20M | $5.400M |
| YoY Change | 181.39% | -85.44% |
| Total Long-Term Assets | $4.321B | $4.138B |
| YoY Change | 4.43% | 1460.7% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $1.988B | $2.172B |
| Total Long-Term Assets | $4.321B | $4.138B |
| Total Assets | $6.309B | $6.309B |
| YoY Change | 0.0% | -21.59% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $67.84M | $86.50M |
| YoY Change | -21.58% | -43.39% |
| Accrued Expenses | $76.01M | $88.40M |
| YoY Change | -14.02% | 47.58% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $15.70M | $13.03M |
| YoY Change | 20.5% | -77.18% |
| Total Short-Term Liabilities | $239.2M | $348.2M |
| YoY Change | -31.29% | 261.02% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $1.495B | $619.2M |
| YoY Change | 141.4% | 1.44% |
| Other Long-Term Liabilities | $195.6M | $157.1M |
| YoY Change | 24.53% | -88.95% |
| Total Long-Term Liabilities | $1.690B | $776.2M |
| YoY Change | 117.75% | 690.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $239.2M | $348.2M |
| Total Long-Term Liabilities | $1.690B | $776.2M |
| Total Liabilities | $2.097B | $2.261B |
| YoY Change | -7.24% | 1061.32% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $4.212B | $4.048B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $6.309B | $6.309B |
| YoY Change | 0.0% | -21.59% |
Cashflow Statement
| Concept | 2021 Q4 | 2020 Q4 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$108.9M | -$904.4M |
| YoY Change | -87.96% | 889.97% |
| Depreciation, Depletion And Amortization | $30.02M | $32.40M |
| YoY Change | -7.35% | 6.37% |
| Cash From Operating Activities | -$167.4M | -$87.60M |
| YoY Change | 91.07% | -53.87% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$2.797M | -$47.42M |
| YoY Change | -94.1% | -72.89% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$22.01M | $286.6M |
| YoY Change | -107.68% | -65.42% |
| Cash From Investing Activities | -$24.81M | $239.2M |
| YoY Change | -110.37% | -63.42% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 343.0K | 18.33M |
| YoY Change | -98.13% | -307.12% |
| NET CHANGE | ||
| Cash From Operating Activities | -167.4M | -87.60M |
| Cash From Investing Activities | -24.81M | 239.2M |
| Cash From Financing Activities | 343.0K | 18.33M |
| Net Change In Cash | -191.8M | 169.9M |
| YoY Change | -212.89% | -62.67% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$167.4M | -$87.60M |
| Capital Expenditures | -$2.797M | -$47.42M |
| Free Cash Flow | -$164.6M | -$40.18M |
| YoY Change | 309.61% | 167.51% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| cgc |
Warrant Value Expiry Of Warrants
WarrantValueExpiryOfWarrants
|
|||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y4M9D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P2Y9M | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | ||
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
30921000 | ||
| us-gaap |
Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
|
18337000 | ||
| us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
83612000 | ||
| us-gaap |
Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
|
10324000 | ||
| us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
7000000 | ||
| us-gaap |
Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
|
374414000 | ||
| cgc |
Investment In Acreage Arrangement
InvestmentInAcreageArrangement
|
49849000 | ||
| cgc |
Loan Advanced To Acreage Hempco
LoanAdvancedToAcreageHempco
|
66995000 | ||
| cgc |
Payments To Acquire Subsidiaries
PaymentsToAcquireSubsidiaries
|
14947000 | ||
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
16759000 | ||
| us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
5269000 | ||
| cgc |
Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
|
1460000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5455000 | ||
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
37999000 | ||
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
244990000 | ||
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
13271000 | ||
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
-578000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
269140000 | ||
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-50539000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-478216000 | ||
| cgc |
Income Taxes Received
IncomeTaxesReceived
|
4176000 | ||
| us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
19078000 | ||
| us-gaap |
Interest Paid Net
InterestPaidNet
|
12886000 | ||
| cgc |
Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
|
5145000 | ||
| cgc |
Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
|
-16220000 | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.52%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.52%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.</p> | ||
| us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
128198000 | ||
| CY2021Q1 | us-gaap |
Cash
Cash
|
436588000 | |
| CY2021Q1 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
718065000 | |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1154653000 | |
| CY2021Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1144563000 | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
1145364000 | |
| CY2021Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
67106000 | |
| CY2021Q1 | us-gaap |
Value Added Tax Receivable
ValueAddedTaxReceivable
|
8281000 | |
| CY2021Q1 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
5140000 | |
| CY2021Q1 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
11908000 | |
| CY2021Q1 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
92435000 | |
| CY2021Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1411000 | |
| cgc |
Other Financial Assets Additions
OtherFinancialAssetsAdditions
|
448684000 | ||
| CY2021Q1 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
55554000 | |
| CY2021Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
223652000 | |
| CY2021Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
88773000 | |
| CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
367979000 | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
48167000 | ||
| CY2021Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
67232000 | |
| CY2021Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
28349000 | |
| CY2021Q1 | cgc |
Prepaid Deposits Current
PrepaidDepositsCurrent
|
18316000 | |
| CY2021Q1 | cgc |
Prepaid Inventory Current
PrepaidInventoryCurrent
|
1496000 | |
| CY2021Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
19071000 | |
| cgc |
Changes In Other Financial Asset Fair Value Through Profit Or Loss
ChangesInOtherFinancialAssetFairValueThroughProfitOrLoss
|
-263946000 | ||
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
9636000 | ||
| us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-3867000 | ||
| cgc |
Exercise Of Options On Investments In Other Financial Assets
ExerciseOfOptionsOnInvestmentsInOtherFinancialAssets
|
177000 | ||
| CY2021Q4 | cgc |
Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
|
898497000 | |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1315593000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1297127000 | |
| CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
235414000 | |
| CY2021Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
222590000 | |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1080179000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1074537000 | |
| CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
354934000 | |
| CY2021Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
223973000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
337456000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
232826000 | |
| CY2021Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
338753000 | |
| CY2021Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
308167000 | |
| CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
76007000 | |
| CY2021Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
100813000 | |
| CY2021Q4 | us-gaap |
Other Long Term Debt
OtherLongTermDebt
|
3155000 | |
| CY2021Q1 | us-gaap |
Other Long Term Debt
OtherLongTermDebt
|
3872000 | |
| CY2021Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
1510367000 | |
| CY2021Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
1582963000 | |
| CY2021Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
15702000 | |
| CY2021Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
9827000 | |
| cgc |
Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
|
1295285 | ||
| cgc |
Number Of Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfSharesIssuedRelatingToCompletionOfAcquisitionMilestones
|
1149086 | ||
| CY2021Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
127073136 | |
| CY2021Q1 | cgc |
Warrants Average Exercise Price
WarrantsAverageExercisePrice
|
58.33 | |
| CY2021Q1 | cgc |
Warrant Value
WarrantValue
|
2568438000 | |
| us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
112939000 | ||
| us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-8798000 | ||
| CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
1988250000 | |
| CY2021Q4 | cgc |
Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
|
7637000 | |
| CY2021Q4 | cgc |
Settlement Liabilities And Other
SettlementLiabilitiesAndOther
|
38529000 | |
| CY2021Q1 | cgc |
Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
|
41349000 | |
| CY2021Q4 | cgc |
Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
|
38684000 | |
| CY2021Q4 | cgc |
Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
|
104300000 | |
| CY2020Q1 | us-gaap |
Goodwill
Goodwill
|
1954471000 | |
| CY2021 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-65117000 | |
| CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
1889354000 | |
| CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
22559000 | |
| CY2021Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
47237000 | |
| CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
7684000 | |
| CY2021Q1 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
13550000 | |
| CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
7319000 | |
| CY2021Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
11544000 | |
| CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
38445000 | |
| CY2021Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
28482000 | |
| CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1494665000 | |
| CY2021Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1573136000 | |
| CY2021Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
750000000 | |
| CY2021Q1 | cgc |
Proceeds From Credit Facility
ProceedsFromCreditFacility
|
893160000 | |
| CY2020Q3 | cgc |
Accretion Rate
AccretionRate
|
0.1106 | |
| CY2020Q3 | cgc |
Conversion Of Outstanding Debentures Description
ConversionOfOutstandingDebenturesDescription
|
In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $38.59 for any 10 consecutive trading days. The Company, Supreme Cannabis and the Trustee entered into a further supplemental indenture whereby the Company agreed to guarantee the obligations of Supreme Cannabis pursuant to the Supreme Debentures and the Accretion Debentures. | |
| CY2021Q4 | cgc |
Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
|
142984000 | |
| CY2021Q1 | cgc |
Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
|
42061000 | |
| CY2021Q1 | cgc |
Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
|
94164000 | |
| CY2021Q1 | cgc |
Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
|
136225000 | |
| CY2021Q4 | cgc |
Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
|
4078000 | |
| CY2021Q4 | cgc |
Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
|
83681000 | |
| CY2021Q4 | cgc |
Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
|
87759000 | |
| CY2021Q1 | cgc |
Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
|
16577000 | |
| CY2021Q1 | cgc |
Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
|
7808000 | |
| CY2021Q1 | cgc |
Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
|
24385000 | |
| CY2021Q4 | cgc |
Refund Liability Current
RefundLiabilityCurrent
|
6046000 | |
| CY2021Q4 | cgc |
Refund Liability
RefundLiability
|
6046000 | |
| CY2021Q1 | cgc |
Refund Liability Current
RefundLiabilityCurrent
|
6441000 | |
| CY2021Q1 | cgc |
Refund Liability
RefundLiability
|
6441000 | |
| CY2021Q4 | cgc |
Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
|
30892000 | |
| CY2021Q1 | cgc |
Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
|
5268000 | |
| CY2021Q1 | cgc |
Settlement Liabilities And Other
SettlementLiabilitiesAndOther
|
46617000 | |
| CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
79700000 | |
| CY2021Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
195618000 | |
| CY2021Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
275318000 | |
| CY2021Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
106428000 | |
| CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
107240000 | |
| CY2021Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
213668000 | |
| CY2021Q4 | cgc |
Estimated Deferred Payments
EstimatedDeferredPayments
|
74160000 | |
| CY2021Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
135300000 | |
| us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-13100000 | ||
| cgc |
Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
|
-48391000 | ||
| CY2021Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
68700000 | |
| CY2020Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
69750000 | |
| us-gaap |
Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
|
-9880000 | ||
| cgc |
Redeemable Noncontrolling Interest Change In Redemption Value
RedeemableNoncontrollingInterestChangeInRedemptionValue
|
51230000 | ||
| CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
111100000 | |
| CY2021Q4 | cgc |
Number Of Equity Financing
NumberOfEquityFinancing
|
0 | |
| CY2020Q4 | cgc |
Number Of Equity Financing
NumberOfEquityFinancing
|
0 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
17737190 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
12368630 | |
| CY2020Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
146299443 | |
| CY2020Q1 | cgc |
Warrants Average Exercise Price
WarrantsAverageExercisePrice
|
52.44 | |
| CY2020Q1 | cgc |
Warrant Value
WarrantValue
|
2638951000 | |
| cgc |
Number Of Whole Warrants On Exercise Of Warrants
NumberOfWholeWarrantsOnExerciseOfWarrants
|
18876901 | ||
| cgc |
Average Exercise Price On Warrant Exercised
AverageExercisePriceOnWarrantExercised
|
12.98 | ||
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
34.17 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
38.05 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
36.79 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
36.97 | |
| cgc |
Number Of Supreme Cannabis Warrants
NumberOfSupremeCannabisWarrants
|
1265742 | ||
| cgc |
Average Of Supreme Cannabis Warrants
AverageOfSupremeCannabisWarrants
|
25.61 | ||
| cgc |
Warrant Value Supreme Cannabis Warrants
WarrantValueSupremeCannabisWarrants
|
13350000 | ||
| cgc |
Number Of Whole Warrants On Expiry Of Warrants
NumberOfWholeWarrantsOnExpiryOfWarrants
|
145831 | ||
| cgc |
Average Exercise Price On Warrant Expiry
AverageExercisePriceOnWarrantExpiry
|
32.61 | ||
| CY2021Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
128193047 | |
| CY2021Q4 | cgc |
Warrants Average Exercise Price
WarrantsAverageExercisePrice
|
58.04 | |
| CY2021Q4 | cgc |
Warrant Value
WarrantValue
|
2581788000 | |
| cgc |
Warrant Value Exercise Of Warrants
WarrantValueExerciseOfWarrants
|
70266000 | ||
| cgc |
Number Of Whole Warrants On Expiry Of Warrants
NumberOfWholeWarrantsOnExpiryOfWarrants
|
343380 | ||
| cgc |
Average Exercise Price On Warrant Expiry
AverageExercisePriceOnWarrantExpiry
|
41.49 | ||
| CY2020Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
127079162 | |
| CY2020Q4 | cgc |
Warrants Average Exercise Price
WarrantsAverageExercisePrice
|
58.30 | |
| CY2020Q4 | cgc |
Warrant Value
WarrantValue
|
2568685000 | |
| CY2020Q3 | cgc |
Extended Period Of Option From Grant Date
ExtendedPeriodOfOptionFromGrantDate
|
P10Y | |
| CY2020Q3 | cgc |
Maximum Period Of Option From Grant Date
MaximumPeriodOfOptionFromGrantDate
|
P6Y | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0121 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0049 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.75 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.73 | ||
| cgc |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
|
0.18 | ||
| cgc |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
|
0.17 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.55 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
23.53 | ||
| cgc |
Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
|
4000000 | ||
| CY2021Q4 | cgc |
Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
|
419884 | |
| cgc |
Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
|
1295285 | ||
| cgc |
Number Of Common Shares Issued Relating To Completion Of Acquisition Milestones
NumberOfCommonSharesIssuedRelatingToCompletionOfAcquisitionMilestones
|
1149086 | ||
| cgc |
Share Based Compensation Number Of Shares To Be Issued On Completion Of Acquisition And Asset Purchase Milestones
ShareBasedCompensationNumberOfSharesToBeIssuedOnCompletionOfAcquisitionAndAssetPurchaseMilestones
|
256057 | ||
| us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
7513000 | ||
| us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-193492000 | ||
| CY2021Q4 | cgc |
Fair Value Transfers Of Amounts Between Levels
FairValueTransfersOfAmountsBetweenLevels
|
0 | |
| CY2020Q4 | cgc |
Fair Value Transfers Of Amounts Between Levels
FairValueTransfersOfAmountsBetweenLevels
|
0 | |
| CY2021Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
140972000 | |
| CY2020Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
152528000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
408555000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
398210000 | ||
| CY2021Q4 | cgc |
Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
|
1000000 | |
| CY2020Q4 | cgc |
Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
|
3750000 | |
| cgc |
Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
|
10900000 | ||
| CY2021Q4 | cgc |
Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
|
6046000 | |
| CY2021Q1 | cgc |
Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
|
6441000 | |
| CY2021Q4 | cgc |
Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
|
68666000 | |
| CY2020Q4 | cgc |
Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
|
-281359000 | |
| cgc |
Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
|
263946000 | ||
| cgc |
Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
|
-385219000 | ||
| CY2021Q4 | cgc |
Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
|
59000000 | |
| CY2020Q4 | cgc |
Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
|
-303000000 | |
| cgc |
Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
|
497000000 | ||
| cgc |
Acreage Arrangement Liability Fair Value Adjustment
AcreageArrangementLiabilityFairValueAdjustment
|
-249849000 | ||
| CY2021Q4 | cgc |
Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
|
606000 | |
| CY2020Q4 | cgc |
Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
|
-75498000 | |
| cgc |
Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
|
81342000 | ||
| cgc |
Convertible Notes Fair Value Adjustment
ConvertibleNotesFairValueAdjustment
|
-107778000 | ||
| CY2021Q4 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-67282000 | |
| CY2020Q4 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
193998000 | |
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-578084000 | ||
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
93455000 | ||
| CY2021Q4 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-712000 | |
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
177993000 | ||
| us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-1044942000 | ||
| CY2021Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
393818282 | |
| CY2020Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
372908767 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
390423083 | ||
| CY2020Q4 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
3066000 | |
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-544000 | ||
| us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-39803000 | ||
| CY2021Q4 | cgc |
Interest Income
InterestIncome
|
1575000 | |
| CY2020Q4 | cgc |
Interest Income
InterestIncome
|
7310000 | |
| cgc |
Interest Income
InterestIncome
|
6977000 | ||
| cgc |
Interest Income
InterestIncome
|
19078000 | ||
| CY2021Q4 | us-gaap |
Interest Expense
InterestExpense
|
26408000 | |
| CY2020Q4 | us-gaap |
Interest Expense
InterestExpense
|
1030000 | |
| us-gaap |
Interest Expense
InterestExpense
|
77618000 | ||
| us-gaap |
Interest Expense
InterestExpense
|
3708000 | ||
| CY2021Q4 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
990000 | |
| CY2020Q4 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
710000 | |
| us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
2902000 | ||
| us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-10290000 | ||
| cgc |
Gain On Acquisition Disposal Of Consolidated Entity
GainOnAcquisitionDisposalOfConsolidatedEntity
|
-1653000 | ||
| CY2021Q4 | cgc |
Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
|
-809000 | |
| CY2020Q4 | cgc |
Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
|
-3354000 | |
| cgc |
Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
|
-12863000 | ||
| cgc |
Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
|
-126000 | ||
| CY2021Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
34282000 | |
| CY2020Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-290567000 | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
810769000 | ||
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-21106000 | ||
| CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-108925000 | |
| CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-904380000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
272435000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1044942000 | ||
| CY2021Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
393818282 | |
| CY2020Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
372908767 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
390423083 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
369418037 | ||
| CY2021Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
| CY2020Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.43 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.70 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.83 | ||
| CY2021Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-108925000 | |
| CY2020Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-904380000 | |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
272435000 | ||
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1044942000 | ||
| us-gaap |
Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
|
13100000 | ||
| cgc |
Convertible Notes Removal Fair Value Adjustment
ConvertibleNotesRemovalFairValueAdjustment
|
81342000 | ||
| CY2021Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-108925000 | |
| CY2020Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-904380000 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
369418037 | ||
| CY2021Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
393818282 | |
| CY2020Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
372908767 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
410986802 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
369418037 | ||
| CY2021Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.28 | |
| CY2020Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.43 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.43 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.83 | ||
| CY2021Q4 | cgc |
Debentures Bear Interest Rate Per Annum
DebenturesBearInterestRatePerAnnum
|
0.061 | |
| CY2019Q2 | us-gaap |
Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
|
2023-11-01 | |
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | ||
| CY2021Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
140972000 | |
| CY2020Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
152528000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
408555000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
398210000 | ||
| CY2021Q4 | us-gaap |
Gross Profit
GrossProfit
|
10090000 | |
| CY2020Q4 | us-gaap |
Gross Profit
GrossProfit
|
24585000 | |
| us-gaap |
Gross Profit
GrossProfit
|
-33812000 | ||
| us-gaap |
Gross Profit
GrossProfit
|
57160000 | ||
| CY2021Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
116835000 | |
| CY2020Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
144078000 | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
355165000 | ||
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
426723000 | ||
| CY2021Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6777000 | |
| CY2020Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
19963000 | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
35856000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
72632000 | ||
| CY2020Q4 | cgc |
Expected Credit Losses On Financial Assets And Related Charges
ExpectedCreditLossesOnFinancialAssetsAndRelatedCharges
|
13735000 | |
| cgc |
Expected Credit Losses On Financial Assets And Related Charges
ExpectedCreditLossesOnFinancialAssetsAndRelatedCharges
|
108480000 | ||
| CY2021Q4 | us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
36439000 | |
| CY2020Q4 | us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
400422000 | |
| us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
128198000 | ||
| us-gaap |
Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
|
459579000 | ||
| CY2021Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-149961000 | |
| CY2020Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-553613000 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-553031000 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1010254000 | ||
| CY2020Q4 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-671000 | |
| us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-100000 | ||
| us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-40851000 | ||
| CY2021Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
34282000 | |
| CY2020Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-290567000 | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
810769000 | ||
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-21106000 | ||
| CY2021Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-115679000 | |
| CY2020Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-844851000 | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
257638000 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1072211000 | ||
| CY2021Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
140972000 | |
| CY2020Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
152528000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
408555000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
398210000 | ||
| CY2021Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
1080179000 | |
| CY2021Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
1074537000 |
